Skip to main content
University of California San Francisco
UCSF School of Medicine | Department of Pediatrics UCSF Medical Center

Impact of diagnostic and end-of-induction Curie scores with tandem high-dose chemotherapy and autologous transplants for metastatic high-risk neuroblastoma: A report from the Children's Oncology Group.

  • Read more about Impact of diagnostic and end-of-induction Curie scores with tandem high-dose chemotherapy and autologous transplants for metastatic high-risk neuroblastoma: A report from the Children's Oncology Group.

Venetoclax in combination with chemotherapy as treatment for pediatric advanced hematologic malignancies.

  • Read more about Venetoclax in combination with chemotherapy as treatment for pediatric advanced hematologic malignancies.

The American Society of Pediatric Hematology Oncology workforce, productivity, and fellowship assessment: Current state of the workforce.

  • Read more about The American Society of Pediatric Hematology Oncology workforce, productivity, and fellowship assessment: Current state of the workforce.

Data standards in pediatric oncology: Past, present, and future.

  • Read more about Data standards in pediatric oncology: Past, present, and future.

Absolute lymphocyte count recovery following initial acute myelogenous leukemia therapy: Implications for adoptive cell therapy.

  • Read more about Absolute lymphocyte count recovery following initial acute myelogenous leukemia therapy: Implications for adoptive cell therapy.

Sirolimus for management of GI bleeding in blue rubber bleb nevus syndrome: A case series.

  • Read more about Sirolimus for management of GI bleeding in blue rubber bleb nevus syndrome: A case series.

Improving infectious adverse event reporting for children and adolescents enrolled in clinical trials for acute lymphoblastic leukemia: A report from the Children's Oncology Group.

  • Read more about Improving infectious adverse event reporting for children and adolescents enrolled in clinical trials for acute lymphoblastic leukemia: A report from the Children's Oncology Group.

Sirolimus efficacy in the treatment of critically ill infants with congenital primary chylous effusions.

  • Read more about Sirolimus efficacy in the treatment of critically ill infants with congenital primary chylous effusions.

An evidence-based, risk-adapted algorithm for antifungal prophylaxis reduces risk for invasive mold infections in children with hematologic malignancies.

  • Read more about An evidence-based, risk-adapted algorithm for antifungal prophylaxis reduces risk for invasive mold infections in children with hematologic malignancies.

Multi-institutional analysis of treatment modalities in basal ganglia and thalamic germinoma.

  • Read more about Multi-institutional analysis of treatment modalities in basal ganglia and thalamic germinoma.

Pagination

  • Previous page ‹‹
  • Page 6
  • Next page ››
Subscribe to Pediatric blood & cancer

Pediatrics Home

MAKE A GIFT

© 2026 The Regents of the University of California. The University of California San Francisco  |  UCSF Department of Pediatrics                                                                                   Accessibility  Privacy Policy  Terms of Use  A-Z Website List